GVOKE (glucagon injection) Xeris Pharmaceuticals, Inc. These highlights do not include all the information needed to use GVOKE safely and effectively. See full prescribing information for GVOKE. GVOKE (glucagon injection), for subcutaneous
FDA OKs Ready-To-Use Gvoke Glucagon By Xeris
Gvoke HydoPen Glucagon Injection 1 mg Per 0.2 mL Autoinjector — Mountainside Medical Equipment
Human Factors Usability and Validation Studies of a Glucagon Autoinjector in a Simulated Severe Hypoglycemia Rescue Situation | Diabetes Technology & Therapeutics
Ready to use Glucagon, no mixing required - Diabetes Technology - TuDiabetes Forum
CLINICAL REVIEW
Using the New Gvoke HypoPen: Glucagon Product Review
FDA Approves Xeris Pharmaceuticals' Glucagon to Treat Severe Hypoglycemia - JDRF
Expanding Glucagon Access and Use in the Prehospital Setting - JEMS: EMS, Emergency Medical Services - Training, Paramedic, EMT News
Company name and structure
Xeris Doses First Patient in Phase 2 Study of Mini-dose Glucagon for mild-moderate hypoglycemia in T1D patients
Harnessing Hypos: Glucagon As An Everyday Tool | Insulin Nation
Gvoke HypoPen - JDRF
G-pen may aid hypoglycemia with type 1 diabetes
Xeris Submits Glucagon Rescue Pen to FDA: A Dramatically Easier and Faster Treatment for Severe Hypoglycemia
Glucagon Options for People with Diabetes - Children with Diabetes
FDA Approves First Ready-to-Use Glucagon Pen - Diabetic Nation
GlucaGen® HypoKit® Official Product Site
Glucagon
Expanding Glucagon Access and Use in the Prehospital Setting - JEMS: EMS, Emergency Medical Services - Training, Paramedic, EMT News
Glucagon
Dasiglucagon well tolerated for severe hypoglycemia
Xeris' glucagon injection Gvoke gains heat with HypoPen auto-injector launch | Fierce Pharma
